SPOKANE, Wash. — As the human genome is unraveled, how will it affect the practice of medicine? A two-part symposium, sponsored by Washington State University’s College of Sciences and designed to provide insight into the question, will be held March 29 in Pullman and March 30 in Spokane.
“Medicine and the Human Genome Project” will address what applications will be made of the new knowledge using the rough draft of the human genome. On March 29, a free, public lecture, “Medical Advances: Heart Disease Now, Gene Therapy Next,” will be delivered by John Brunzell at 7:30 p.m. at WSU’s Compton Union Building Auditorium in Pullman. Medical practitioners and the public are invited to attend. The March 30 professional session featuring three presenters will be held from 8 a.m. to noon at the Deaconess Health and Education Building in Spokane.
Brunzell is a physician, director of the Gene and Cell Therapy Lab at the University of Washington School of Medicine, and an authority on lipid metabolism. Other speakers are physician Anthony Blau, assistant project director for the Clinical Research Center for Gene Therapy at the UW School of Medicine, who will discuss regulating cell therapy using drugs; and Tarif Awad, manager of Worldwide Applications Lab, Affymetrix Corp., who will explore microarray technology and its impact on diagnostics and biomedical research.
Registration is required for the Spokane professional lectures, and professional development contact hours are available. There is no charge for the general public to attend. For registration information, contact the Area Health Education Center, WSU Spokane, 509/358-7640, 800/279-0705 or firstname.lastname@example.org.
The Eastlick Symposium honors WSU professor Herbert Eastlick, who served as the premed adviser at WSU for many years. Eastlick steered many physicians now practicing in the Inland Northwest toward a career in medicine. The Eastlick Endowment Fund provides an annual lectureship in biomedical sciences.
For more information, call the College of Sciences, 509/335-5548.